G GNA BIOSOLUTIONS
LIVE

Serial Number

79218926

Owner

GNA Biosolutions GmbH

Attorney

Jacqueline Zion

Filing Date

Jul 28, 2017

Add to watchlist:

No watchlists yet
View on USPTO

G GNA BIOSOLUTIONS Trademark

Serial Number: 79218926 • Registration: 5705753

G GNA BIOSOLUTIONS is a trademark filed by GNA Biosolutions GmbH on July 28, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GNA Biosolutions GmbH (10 trademarks)

Am Klopferspitz 19
82152 Martinsried , DE

Entity Type: 99

Trademark Details

Filing Date

July 28, 2017

Registration Date

March 26, 2019

Published for Opposition

January 8, 2019

Cancellation Date

October 10, 2025

Goods & Services

Updating of computer software; maintenance of software; biological research; cloud computing featuring software for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; chemical laboratories; chemical analysis; bacteriological research; chemical research; research and development of new products for others; conducting clinical trials for others for scientific and medical research; medical and scientific research services; scientific laboratory services; clinical laboratory services for scientific purposes; scientific and technological services and research and design relating thereto, namely, conducting bioanalytical procedures; industrial analysis and research services, namely, conducting bioanalytical procedures, in particular nucleic acid amplification and detection for scientific research purposes; design and development of computer hardware and software; scientific analysis of cells, proteins, nucleic acids and other molecules between 50 and 10 000 daltons, for DNA sequencing and genotyping, for detecting DNS mutations, for gene expression profiling, in particular relating to the conducting of high throughput screening methods; information and advice relating to the aforesaid services; development and conducting of scientific analyses and diagnostic methods, for others

Biochips for research or scientific purposes; diagnostic apparatus, not for medical purposes, namely, for bioanalytical purposes, in particular for nucleic acid amplification and detection; computer software applications, downloadable, for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; lasers, not for medical purposes; chemistry apparatus and instruments, namely, for bioanalytical procedures; recorded computer programs for setting up, conducting interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; downloadable computer software programs for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; recorded computer software for setting up, conducting, interpreting, and storing bioanalytical measurements, in particular for nucleic acid amplification and detection; DNA chips; air analysis apparatus; optical apparatus and instruments, namely, for bioanalytical measurements; laboratory equipment, namely, test tubes; probes for scientific purposes for conducting bioanalytical measurements, in particular for nucleic acid amplification and detection; scientific, electrotechnical, electronic, optical, measuring, signaling, checking, and supervision apparatus and instruments, namely, for conducting bioanalytical procedures, in particular sample preparation, nucleic acid amplification and detection; laboratory apparatus, analysis apparatus and parts therefor, namely, for conducting bioanalytical procedures, in particular sample preparation, nucleic acid amplification and detection; scanners; laboratory equipment, in particular apparatus for bioanalysis, in particular temperature cyclers, fluorescence scanners and apparatuses for nucleic acid amplification and detection, in particular using a cartridge for preparing samples, purifying nucleic acids and amplifying nucleic acids and for detecting nucleic acids; disposable articles for laboratory apparatus, in particular sample and receptacles, mainly consisting of plastic; parts and fittings for all the aforesaid, namely, mechanical, electrical, and structural modules or components

Diagnostic chemical reagents for medical use; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for veterinary purposes; diagnostic biomarker reagents for medical purposes; diagnostic testing materials for medical use testing of the intended performance characteristics of bioanalytical methods; diagnostic reagents for medical use; clinical medical reagents; reagents for in-vitro laboratory use for medical purposes; reagents for in-vitro laboratory use for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use with analyzers for medical purposes

Apparatus for DNA and RNA exams for medical purposes; blood testing apparatus; diagnostic apparatus for medical purposes for detecting target molecules of interest in a sample, in particular a patient sample; lasers for medical purposes; medical apparatus, in particular apparatus for bioanalysis, namely, the extraction, amplification, and detection of target molecules of interest; diagnostic apparatus for veterinary purposes for detecting target molecules of interest; automatic analyzers for medical diagnosis for detecting target molecules of interest; medical apparatus and instruments, namely, for detecting target molecules of interest; medical instruments for infectious disease testing, namely, human or veterinary pathogens; medical and veterinary apparatus and instruments, namely, for processing samples, and detecting target molecules of interest; tools for veterinary diagnostics, namely, detecting target molecules of interest

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 10, 2026 INTR
CANCELLED SECTION 71
Oct 10, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 26, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 9, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 16, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 25, 2019 FICS
FINAL DISPOSITION PROCESSED
Jul 25, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 26, 2019 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 5, 2019 OPNX
REGISTERED-PRINCIPAL REGISTER
Mar 26, 2019 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 20, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 20, 2019 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 8, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 8, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 19, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 30, 2018 PREV
ASSIGNED TO LIE
Nov 29, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 8, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 8, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 8, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 8, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 8, 2018 CNEA
REFUSAL PROCESSED BY IB
Oct 6, 2018 RFNP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2018 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2018 GNRT
NON-FINAL ACTION WRITTEN
Aug 7, 2018 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 9, 2018 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 26, 2018 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2018 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Mar 23, 2018 NREP
REFUSAL PROCESSED BY IB
Dec 17, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 28, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 28, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 15, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 14, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 31, 2017 MAFR
ASSIGNED TO EXAMINER
Oct 28, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 19, 2017 REPR